WO2006117700A3 - Process for preparing quetiapine and quetiapine fumarate - Google Patents

Process for preparing quetiapine and quetiapine fumarate Download PDF

Info

Publication number
WO2006117700A3
WO2006117700A3 PCT/IB2006/002286 IB2006002286W WO2006117700A3 WO 2006117700 A3 WO2006117700 A3 WO 2006117700A3 IB 2006002286 W IB2006002286 W IB 2006002286W WO 2006117700 A3 WO2006117700 A3 WO 2006117700A3
Authority
WO
WIPO (PCT)
Prior art keywords
quetiapine
dibenzo
fumarate
preparing
thiazepine
Prior art date
Application number
PCT/IB2006/002286
Other languages
French (fr)
Other versions
WO2006117700A2 (en
Inventor
Llado Jordi Bosch
Montero Maria Carme Burgarolas
Gutierrez Iolanda Chamorro
Original Assignee
Medichem Sa
Llado Jordi Bosch
Montero Maria Carme Burgarolas
Gutierrez Iolanda Chamorro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US67337305P priority Critical
Priority to US60/673,373 priority
Priority to US73086405P priority
Priority to US60/730,864 priority
Application filed by Medichem Sa, Llado Jordi Bosch, Montero Maria Carme Burgarolas, Gutierrez Iolanda Chamorro filed Critical Medichem Sa
Publication of WO2006117700A2 publication Critical patent/WO2006117700A2/en
Publication of WO2006117700A3 publication Critical patent/WO2006117700A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16[b, f]-condensed

Abstract

The invention comprises a process for preparing quetiapine and/or its salts, including, quetiapine fumarate. The process generally comprises reacting dibenzothiazepinone (dibenzo[bf][l,4]thiazepin-l l(10H)-one) with phosphorous oxychloride in the presence of triethylamine in an aromatic organic solvent such as toluene or, preferably, xylene at reflux temperature to obtain an aromatic hydrocarbon solution of 11-chloro-dibenzo [bf] [1,4] thiazepine. Thereafter, the l l-chloro-dibenzo[bf][1,4] thiazepine is reacted with 2-(2-piperazin-l-ylethoxy)-ethanol to yield, following several processing steps, quetiapine.. Compound I can then be further reacted with fumaric acid at elevated temperature to yield quetiapine fumarate. The resulting quetiapine fumarate obtained is suitable for use in pharmaceutical preparations.
PCT/IB2006/002286 2005-04-21 2006-04-21 Process for preparing quetiapine and quetiapine fumarate WO2006117700A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US67337305P true 2005-04-21 2005-04-21
US60/673,373 2005-04-21
US73086405P true 2005-10-28 2005-10-28
US60/730,864 2005-10-28

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06765649A EP1879874A2 (en) 2005-04-21 2006-04-21 Process for preparing quetiapine and quetiapine fumarate
CA2605473A CA2605473C (en) 2005-04-21 2006-04-21 Process for preparing quetiapine and quetiapine fumarate
US11/911,898 US8048876B2 (en) 2005-04-21 2006-04-21 Process for preparing quetiapine and quetiapine fumarate

Publications (2)

Publication Number Publication Date
WO2006117700A2 WO2006117700A2 (en) 2006-11-09
WO2006117700A3 true WO2006117700A3 (en) 2007-03-01

Family

ID=37308368

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/002286 WO2006117700A2 (en) 2005-04-21 2006-04-21 Process for preparing quetiapine and quetiapine fumarate

Country Status (5)

Country Link
US (1) US8048876B2 (en)
EP (1) EP1879874A2 (en)
AR (1) AR053237A1 (en)
CA (1) CA2605473C (en)
WO (1) WO2006117700A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006113425A1 (en) 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Process for preparing quetiapine fumarate
HU230144B1 (en) * 2007-06-12 2015-09-28 Richter Gedeon Nyrt. Process for producing quetiapine
JP5343362B2 (en) * 2008-01-23 2013-11-13 住友化学株式会社 Process for producing bis {2- [2- (4-dibenzo [b, f] [1,4] thiazepin-11-yl-1-piperazinyl) ethoxy] ethanol} monofumarate
WO2009095529A1 (en) * 2008-01-31 2009-08-06 Fermion Oy A process for the preparation of quetiapine
WO2009113051A2 (en) * 2008-03-12 2009-09-17 Dexcel Ltd. Oral modified-release formulations containing thiazepines
EP2153834A3 (en) * 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
JP2010053044A (en) * 2008-08-26 2010-03-11 Sumitomo Chemical Co Ltd Method for producing 11-chlorodibenzo[b,f][1,4]thiazepine
EP2370432A2 (en) * 2008-12-15 2011-10-05 Alembic Limited A process for preparing quetiapine fumarate
WO2010100623A1 (en) 2009-03-04 2010-09-10 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
CN101940561A (en) * 2010-09-14 2011-01-12 浙江华海药业股份有限公司 Quetiapine fumarate tablet and preparation method thereof
CN108586385B (en) * 2017-12-26 2020-03-20 山东安信制药有限公司 Method for preparing large-particle-size quetiapine fumarate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240228A1 (en) * 1986-03-27 1987-10-07 Ici Americas Inc. Thiazepine compounds
WO2001021179A1 (en) * 1999-09-21 2001-03-29 Astrazeneca Ab Quetiapine granules
WO2002094236A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of antipsychotics through an inhalation route
US20050003001A1 (en) * 2001-11-07 2005-01-06 Hisami Yamaguchi Method for improving dissolution of poorly dispersible medicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286722A (en) 1990-07-24 1994-02-15 Akzo N.V. Tetrahydropyridinyldibenzazepine derivatives
AU2003235435A1 (en) 2002-03-20 2003-10-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of quetiapine hemifumarate
TR200503401T1 (en) 2003-03-03 2008-03-21 Hetero Drugs Limited Quetiapine new polymorphs of Fumarate
KR101038389B1 (en) 2004-06-23 2011-06-01 에스케이바이오팜 주식회사 Process for the preparation of 11-4-[2-2-hydroxyethoxyethyl]-1-piperazinyldibenzo[b,f][1,4]thiazepine
US20060063927A1 (en) 2004-09-22 2006-03-23 Olga Etlin Processes for preparing quetiapine and salts thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240228A1 (en) * 1986-03-27 1987-10-07 Ici Americas Inc. Thiazepine compounds
WO2001021179A1 (en) * 1999-09-21 2001-03-29 Astrazeneca Ab Quetiapine granules
WO2002094236A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of antipsychotics through an inhalation route
US20050003001A1 (en) * 2001-11-07 2005-01-06 Hisami Yamaguchi Method for improving dissolution of poorly dispersible medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1879874A2 *

Also Published As

Publication number Publication date
US20090076262A1 (en) 2009-03-19
CA2605473A1 (en) 2006-11-09
WO2006117700A2 (en) 2006-11-09
EP1879874A2 (en) 2008-01-23
AR053237A1 (en) 2007-04-25
US8048876B2 (en) 2011-11-01
CA2605473C (en) 2013-10-29

Similar Documents

Publication Publication Date Title
WO2006117700A3 (en) Process for preparing quetiapine and quetiapine fumarate
You et al. A biomimetic synthesis of thiazolines using hexaphenyloxodiphosphonium trifluoromethanesulfonate
WO2007026971A3 (en) Process for preparing benzazepine compounds or salts thereof
EP2292607A3 (en) Process for the synthesis of organic compounds
EP2325189A3 (en) Chemical coupling process with a phenyl boronic acid derivative
EP1038875A3 (en) Imidazopyridine derivatives and process for making them
NO20071710L (en) Process for the preparation of phenoxybenzamide compounds
Lukáč et al. Dialkylamino and nitrogen heterocyclic analogues of hexadecylphosphocholine and cetyltrimetylammonium bromide: Effect of phosphate group and environment of the ammonium cation on their biological activity
NO20063661L (en) Process for the preparation of dibenzothiazepine derivatives
BG106122A (en) Thiazolidinedion derivative and its use as antidiabetic
EP1375499A8 (en) Process for the production of 2-(5-methyl-4-oxazolyl)ethanol derivatives
AU618392B2 (en) Fused dibenzooxe (thie) pine derivatives.
ES2159488A1 (en) Method for preparing pyrimidone derivatives with antifungal activity
IL173524D0 (en) Production process of optically pure 2-(4-hydroxyphenoxy)- propanoic acid compounds
MXPA05013715A (en) Processes for preparing (2s)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid derivatives.
AU2001241999A1 (en) Process for organic acid bioleaching of nickel ore
WO2004016589A3 (en) Process for production of highly pure donepezil hydrochloride
NZ513551A (en) Novel process for preparing alendronic acid
AR023567A1 (en) A PROCEDURE TO PREPARE A HYDROCHLORIDE MONOHIDRATE DERIVED FROM TIAZOLIDIN-2,4-DIONA
US7495096B2 (en) Processes for the production of chinazoline alkaloids
NZ510316A (en) Preparing 5-[4-[[-3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione derivative
AU704728B2 (en) 1-{omega-(3,4-dihydro-2-naphthalenyl)alkyl} cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
CA2262159C (en) A process for preparing carbamazepine from iminostilbene
TWI404720B (en) Manufacturing method of imidazo[1,2-b]pyridazine compound
Yang et al. Synthesis and in vitro antimicrobial activity of benzo [b][1, 4] thiazin-3 (4H)-ones via smiles rearrangement

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2605473

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006765649

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2006765649

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11911898

Country of ref document: US